Michael Gelband’s Fresenius Medical Care FMS Stock Holding History

Michael Gelband’s Portfolio FMS Stock Details FMS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-33,541	Closed	-$471K	–	1783
2022 Q3	$471K	Buy	+33,541	New	+$634K	0.01%	1387
2022 Q1	–	Sell	-6,687	Closed	-$217K	–	2335
2021 Q4	$217K	Buy	+6,687	New	+$220K	﹤0.01%	1793
2021 Q2	–	Sell	-7,667	Closed	-$283K	–	2499
2021 Q1	$283K	Buy	+7,667	New	+$290K	﹤0.01%	1715
2020 Q2	–	Sell	-11,559	Closed	-$379K	–	1852
2020 Q1	$379K	Buy	11,559 +4,185	+57%	+$156K	0.02%	579
2019 Q4	$272K	Buy	+7,374	New	+$261K	0.01%	1195
2019 Q3	–	Sell	-23,600	Closed	-$927K	–	1433
2019 Q2	$927K	Buy	+23,600	New	+$935K	0.04%	269

Other funds holding FMS

Pzena Investment Management New York $34.1B AUM 23.81% 1-Year Est. Return

FMI

Fiduciary Management Inc Milwaukee, Wisconsin $7.03B AUM 11.68% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return

Michael Gelband's FMS Position: Q4 2022 in Review

Michael Gelband sold out of Fresenius Medical Care (FMS) in Q4 2022, closing a stake of 33,541 shares — an estimated $471K sold.

Michael Gelband first reported a position in FMS in Q2 2019 and held it in 6 quarters. The position peaked at $927K in Q2 2019. 155 funds tracked by Wall St. Rank hold FMS as of Q4 2022.

Michael Gelband reported no remaining Fresenius Medical Care position as of Q4 2022 after selling out during the quarter.
Michael Gelband sold 33,541 Fresenius Medical Care shares in Q4 2022, an estimated $471K.
Michael Gelband first reported a position in Fresenius Medical Care in Q2 2019 and held it in 6 quarters.
Michael Gelband's Fresenius Medical Care position peaked at $927K in Q2 2019.
155 funds tracked by Wall St. Rank held Fresenius Medical Care as of Q4 2022.

Based on ExodusPoint Capital Management's 13F filing for Q4 2022, filed 13 Feb 2023.